常见人体肿瘤转移动物模型的建立及相关机理研究
|
摘要
转移性是恶性肿瘤主要的生物学特性之一，也是导致肿瘤患者死亡的主要原因，即使对患者实施肿瘤切除，术后转移的发生也是影响手术疗效的主要障碍。肿瘤转移的发生发展是一个多因素、多步骤的复杂生物学过程。因此，研究肿瘤的转移，就必然要建立与临床表现相近的肿瘤转移动物模型。人体肿瘤移植于裸小鼠建立人癌异种移植动物模型为肿瘤的深入研究提供了可能。皮下移植和原位移植是目前常用的两种方法。原位移植由于获得与人体肿瘤生长相似的微环境，更利于肿瘤恶性行为的表达，因此，建立肿瘤转移动物模型大多采用原位移植的方法。肝癌、胃癌和肺癌是常见的肿瘤，利用这三种肿瘤进行研究具有一定的代表意义。本课题利用不同程度免疫缺陷小鼠观察了人肝癌原位移植肿瘤在宿主体内的生物学特性差异；模拟临床，建立了人肝癌和人肺癌术后转移动物模型；同时利用经体内筛选建立的人胃癌高转移动物模型以及建立的人胃癌细胞株MKN-45mc，对肿瘤转移的相关机制进行探讨。
一、目的
1．建立人肝癌NOD-SCID小鼠和裸小鼠原位移植模型，并通过两种模型生物学特性的比较，对不同类型免疫缺陷动物在人肝癌异种移植方面的应用价值进行初步探讨。
2．建立人肝癌术后转移动物模型，观察并比较手术切除肿瘤后对人肝癌小鼠皮下移植模型和原位移植模型的影响。
3．建立裸小鼠人肺癌术后转移模型，为研究肺癌的转移机制和术后抗转移治疗提供适宜的动物模型。
4．比较体内筛选前后建立的人胃癌原位移植动物模型，以及人胃癌细胞株MKN-45mc和MKN-45生物学特性出现的差异，对转移的相关机制进行探讨。
二、方法
1．将组织结构完整的SMMC-LTNM瘤块植入NOD-SCID小鼠和裸小鼠肝脏内，建立人肝癌原位移植模型。观察成瘤率、肿瘤体积和重量、脏器的转移情况以及血清甲胎蛋白(AFP)、γ-谷氨酰转肽酶同工酶Ⅱ(γ-GTⅡ)等指标。
2．将组织结构完整的HC-031瘤块植入NOD-SCID小鼠皮下和肝脏内，分别建立人肝癌皮下移植和原位移植模型。模拟临床肿瘤手术切除方法，切除皮下移植瘤和原位移植瘤，建立肝癌术后转移模型。观察肿瘤生长和动物的生存状况。通过病理解剖和组织病理学技术研究肿瘤在动物体内转移情况。
3．将人非小细胞肺癌NCI-H460组织块植入裸小鼠皮下，建立皮下移植瘤模型。4w后，25只裸小鼠作为手术组切除肿瘤组织，建立术后转移模型，15只裸小鼠作为对照组。每两周两组各处死5只动物动态观察其远处各脏器转移情况。动物明显消瘦时结束实验。采用免疫组化方法检测MMP-2、OPN、CD44v6、CD62等蛋白在转移灶及原发灶的表达情况。
4．用人胃癌MKN-45sci和MKN-45肿瘤组织块建立人胃癌原位移植动物模型，观察并比较两种模型的肿瘤生长和转移、血清肿瘤标志物及MMP-2、OPN、CD44v6、CD62与Timp-2的表达情况。取MKN-45sci肝转移灶形成的皮下移植瘤，用组织块法进行原代培养，建立MKN-45mc细胞株，观察肿瘤细胞的形态学、生长速度、体外侵袭能力、细胞周期变化，并与MKN-45细胞株进行比较。
三、结果
1．NOD-SCID小鼠人肝癌原位移植模型于5w可扪及肿瘤的生长，成瘤率为100％，11w肿瘤体积为(4.48±0.93)cm~3，瘤重为(7.02±1.15)g，肺部转移率为53.85％；裸小鼠人肝癌原位移植模型于6w～7w可扪及肿瘤的生长，成瘤率为100％，11w肿瘤体积为(1.02±0.70)cm~3，瘤重为(2.87±0.44)g，体内未见转移发生。NOD-SCID小鼠的瘤体积、瘤重、肺转移率均高于裸小鼠(P=0.000，P=0.000，P=0.011)。二者均保持AFP高分泌和γ-GT同工酶阳性的特性。
2．人肝癌HC-031皮下移植模型和原位移植模型由于肿瘤负荷过大分别于11w和6w而出现濒死状态，荷瘤平均生存时间为75d和44d。病理解剖，皮下移植瘤模型未发现转移(0／7)，原位移植瘤模型的肿瘤和邻近脏器侵袭明显，部分出现肺部转移(2／7)。皮下切瘤动物和肝原位切瘤动物分别于17w和12w出现恶病质现象，平均生存时间为154d和112d。病理解剖发现肺部均有肉眼可见癌性转移结节(7／7，7／7)。未切瘤动物和切瘤动物血清中AFP和γ-GTⅡ表达均为阳性。
3．人肺癌NCI-H460裸小鼠皮下移植瘤10w时瘤体严重坏死，并且动物出现明显消瘦，解剖未发现转移。手术组裸小鼠于10w、12w各发现一例肺转移(1／5)，14w时裸小鼠明显消瘦，肺转移率达100％(5／5)，有肉眼明显可见的肺转移结节，其他脏器未见转移。免疫组化结果表明，MMP-2、OPN、CD44v6、CD62和Timp-2在肺转移灶内的表达明显高于原发灶，CD54和MMP-9在转移灶内的表达则低于原发灶。
4．人胃癌原位移植模型MKN-45sci组动物的肝转移出现早且转移率高，4w左右肉眼即可看到肝转移结节(100％)，同时伴有淋巴结转移(100％)、肺转移(71％)、脾转移(29％)和腹水；移植瘤体积和重量明显增加，分别达到(3089±1617)mm~3和(2.66±1.32)g，动物出现恶病质。而4w时MKN-45组肝、肺、脾未见明显转移灶，仅2只动物有淋巴结转移；小鼠未见明显消瘦，移植瘤体积和重量为(275±90)mm~3和(0.35±0.14)g。MKN-45sci组血清中NSE和CYFRA21-1的浓度均较高，且随着肿瘤生长时间的延长而增高。而MKN-45组CYFRA21-1始终呈现阴性，4w时NSE仅为76.9 ng／ml。免疫组化结果显示MMP-9、OPN抗体在MKN-45sci组原位移植瘤和转移灶呈强阳性反应，而在MKN-45组原位移植瘤反应较弱。CD44v6抗体在MKN-45sci组原位移植瘤和转移灶呈阳性反应。E-cadherin抗体在MKN-45sci组原位移植瘤呈阳性反应，肝转移灶呈阴性反应。建立的MKN-45mc细胞株的染色体为超三倍体细胞，具有人类恶性肿瘤细胞染色体的特点。细胞形态为典型的上皮样细胞，与MKN-45的形态学特点相似。流式细胞分析显示MKN-45mc与MKN-45细胞周期各时相比例分别为：G_0-G_1期62.51％／53.95％，S期9.46％／1452％，G_2-M期28.04％／31.53％，两株细胞DNA合成期的细胞比例均较高。MKN-45mc与MKN-45细胞倍增时间分别为34.8h和42.1h，前者的生长速度高于后者。MKN-45mc与MKN-45的36h体外过膜数分别为(60.38±8.86)／高倍视野和(32.50±17.26)／高倍视野，前者多于后者。
四、结论
1．建立了与临床表现相似的人肝癌动物模型。与裸小鼠相比，NOD-SCID小鼠在建立人肝癌的异种移植模型方面有更大的应用价值。
2．模拟临床肿瘤切除方法，建立人肝癌术后转移动物模型。实验结果表明，荷瘤动物肿瘤切除后，生存期延长，有利于肿瘤转移发生。
3．裸小鼠人肺癌术后转移模型模拟了临床肿瘤根除术后发生远处转移的过程，结果提示肺癌转移的发生可能与部分粘附分子的异常表达相关，同时为研究肺癌转移机制和术后抗转移治疗提供理想的动物模型。
4．人胃癌原位移植动物模型体内筛选前后肿瘤的生物学特性不同，经筛选后肿瘤的生长和转移能力较未筛选的增强，其机理与肿瘤细胞粘附和降解能力得到强化有关。筛选后建立的细胞株生长速度、过膜能力比原细胞株增强，表明肿瘤转移与肿瘤细胞增殖和运动变形能力有关。
Metastasis is one of the most important biological characteristics on malignanttumor, and is the main cause of death for most cancer patients and thus is a majorobstacle to the successful treatment of such patients. Even if had tumour-reductivesurgery(TRS) for cancer patients, postoperative metastasis is the main obstruct thatimpact the curative effect of operation. The occurance and development of tumormetastasis is a complicated process of biological change finished by multiple factorsand steps. Therefore, it's necessary to generate the animal model of tumor metastasiswhich is close to the clinical condition for study of tumor metastasis. The animalmodel of human carcinoma xenotransplantation, established by transplanting humancarcinoma into nude mice, provides the possibility to investigate tumor deeply. Bothsubcutaneous implantation and orthotopic transplantation are two common methodsto produce these models. Due to obtain microenvironment the same as the situationsin human body, orthotopic transplantation is easier to express the malignant tumorbehavior. Thus, orthotopic transplantation is the main method to establish animalmodel of tumor metastasis.Liver cancer, gastric cancer and lung cancer, the prevalentcarcinoma, have representative significance if research on them.In this study, weobserved the difference of the biological characteristics in parasitifer on orthotopic into the subscutaneousness and liver of NOD-SCID mice. Then having TRS for tumorof subcutaneous implantation and orthotopic transplantation, we established a modelof postoperative metastasis of HCC by imitating clinical operation method. Weobserved the tumor growth and animal survival condition, and investigated metastasisin vivo by pathological anatomy and histopathology technology.
3. To establish the NCI-H460 subcutaneous metastasis model of nonsmall-celllung cancer (NSCLC) by using the histological intact tumor tissue. Four weeks later,40 nude mice were selected as operation group and had tumor resection to establishthe postoperative metastasis model at random. The rest were assigned to the controlgroup. Then five mice were sacrificed and dissected every two weeks to observe themetastasis in two groups. All of mice were sacrificed when animals were obviouslyslender, and subsequently detect the expression of MMP-2, OPN, CD44v6, CD62, etc,in metastases and primary tumor by immunohistochemistry (IHC).
4. We established orthotopic transplantation models of human gastric cancer innude mice using histologically intact tissue of MKN-45sci and MKN-45.The resultson growth, metastasis, markers in serum and expression of MMP-2, OPN, CD44v6,CD62 and Timp-2 of tumor in two models were observed. We established cell strainMKN-45mc, which was derived from a subcutaneous tumor that was grown into fromliver metastasis of MKN-45sci. We observed cell morphology, cell growth velocity,invasive power in vitro, change of cell cycle on cell strain MKN-45mc, and comparedwith strain MKN-45
Results:
1. The growth rate of the tumor was 100％in the orthotopic transplantationmodel of human hepatocellular carcinoma in NOD-SCID mice. The tumor inNOD-SCID mice was palpable at the 5th week. The volume, the weight and the lungmetastasis rate of the tumor was (4.48±0.93)cm~3, (7.02±1.15)g and 53.85％in NOD-SCID mice at the 11th week respectively. Growth rate of tumor was 100％inthe orthotopic transplantation model of human hepatocellular carcinoma in nude mice.The tumor was palpable between the 6th week and the 7th week. The volume, theweight of the tumor was(1.02±0.70)cm~3 and (2.87±0.44)g in nude mice at the 11thweek respectively, while no metastasis. The volume, the weight, the metastasis rate ofthe tumor in NOD-SCID mice were all significantly higher than those in nude mice(P=0.000, P=0.000, P=0.011). The two kinds of animals all kept the characteristics:highly secrete AFP highly and positiveγ-GTⅡ.
2. The models of subcutaneous implantation and orthotopic transplantation wereon the brink of death because of overload of tumor at the 11th and 6th week,separately. The average survival time of the two kinds of models is 75d and 44drespectively. By pathological anatomy, metastasis (0/7) was not observed in model ofsubcutaneous implantation. Metastasis in lung (2/7) was observed in the model oforthotopic transplantation and the tumor obviouslly invaded the adjacent organs. Theanimals after TRS to the model of subcutaneous implantation and orthotopictransplantation were on the brink of death at the 17w and 12w respectively. Theaverage survival time of them is 75d and 44d, respectively. Metastasis nodes in lungcould be found with naked eyes (7/7,7/7). The expression of AFP andγ-GTⅡin theserum of animals via both resection and non-resection was positive.
3. Mice in control group, non-metastasis in each stage, were the expression ofobvious emaciation and tumor necrosis after 10 weeks. While in the operation group,the metastasis rate was 20％(1/5) in lung when mice were sacrificed at 10 and 12weeks. The metastasis rate was 100％(5/5) in lung when the mice were sacrificed at14 weeks with non-metastasis in other organs. The IHC results indicate that theexpression of MMP-2, OPN, CD44v6, CD62 and Timp-2 in metastases were higherthan in primary tumor, while the expression of CD54 and MMP-9 in metastases were lower than that in primary tumor.
4. The metastasis in liver in MKN-45sci group was earlier occurrence and higherpercentage. At the 4th week, the metastasis percentage in liver, lymphonode, lung,spleen and abdominal dropsy is 100％, 100％, 71％, 29％and 29％, respectively. Thevolume and weight of transplantation tumor obviously increased to (3089+1617)mm~3and (2.66±1.32)g. The cachexia occurred to the animal in MKN-45sci group at the4th week. Whereas the metastasis in liver, lung and spleen in MKN-45 group was notobvious at the same time other than lymphonode in two mice. The volume and weightof transplantation tumor were (275±90)mm~3 and (0.35±0.14)g. The animal inMKN-45 group was not obvious emaciation. The density of NSE and CYFRA21-1 inserum in MKN-45sci group was much greater, which could enhance with theprolongation of the time that tumor grew. But CYFRA21-1 in MKN-45 group wasnegative all the time, and NSE was merely 76.9ng/ml at the 4th week. The IHCresults indicated, the expression of MMP-9 and OPN was higher in transplantationtumor and metastasis in MKN-45sci group, but lower in transplantation tumor inMKN-45 group; CD44v6 in transplantation tumor and metastasis in MKN-45sci ispositive; the expression of E-cadherin in MKN-45sci was deteced in orthotopictransplantation tumor, and not tested in metastasis in liver. The chromosome of cellstrain MKN-45mc established embodied the characteristics of that of humammalignant tumor cell, which was hypertriploid. Its characteristics of cell morphologywas similar to MKN-45, which was typical epitheliod cell. The phase proportion ofcell circle of MKN-45mc and MKN-45 was 62.51％/53.95％in G_0-G_1, 9.46％/14.52％in S, 28.04％/31.53％in G_2-M respectively via flow cytometry. The cell quantity oftwo cell strains was more greater in DNA synthesis phase. The cell growth velocity ofMKN-45mc was higher than that of MKN-45, whose double time was 34.8h and42.1h. The number of cell penetrating through membrane in MKN-45mc was greater than that in MKN-45 in 36 hours, which was (60.38±8.86) and (32.50±17.26) inhighpower field.
Conclusion:
1. We have established the animal model of HCC that is similar to the clinic. Theapplication significance in NOD-SCID mice is greater than that in nude mice as far asestablishing xenotransplantation model of HCC.
2. We establish animal model of postoperative metastasis of human HCC byTRS in clinic. The results show that resection is easier to the development ofmetastasis in the animal bodies bearing cancer due to prolongation of life span.
3. This animal model simulates the metastasis after clinical operation, and theIHC results indicated that metastasis is in correlation with some adhesion molecules.This kind of model provides valuable data to study mechanism of NSCLC metastasisand treatment of human NSCLC.
4. The biological characteristics on orthotopic transplantation models of humangastric cancer in animal is different after filtration or non-filtration.The capability oftumor growth and metastasis which has been filtered is greater than which not filtered,which mechanism could be associated with strengthening adhesion and degradationof tumor cells. The growth velocity and invasive power in vitro of the cell strainwhich has been filtered is greater than the cell strain which not filtered, whichindicates that the ability of cell metastasis has relationship with the ability of cellmultiplication and metamorphosis.
一、目的
1．建立人肝癌NOD-SCID小鼠和裸小鼠原位移植模型，并通过两种模型生物学特性的比较，对不同类型免疫缺陷动物在人肝癌异种移植方面的应用价值进行初步探讨。
2．建立人肝癌术后转移动物模型，观察并比较手术切除肿瘤后对人肝癌小鼠皮下移植模型和原位移植模型的影响。
3．建立裸小鼠人肺癌术后转移模型，为研究肺癌的转移机制和术后抗转移治疗提供适宜的动物模型。
4．比较体内筛选前后建立的人胃癌原位移植动物模型，以及人胃癌细胞株MKN-45mc和MKN-45生物学特性出现的差异，对转移的相关机制进行探讨。
二、方法
1．将组织结构完整的SMMC-LTNM瘤块植入NOD-SCID小鼠和裸小鼠肝脏内，建立人肝癌原位移植模型。观察成瘤率、肿瘤体积和重量、脏器的转移情况以及血清甲胎蛋白(AFP)、γ-谷氨酰转肽酶同工酶Ⅱ(γ-GTⅡ)等指标。
2．将组织结构完整的HC-031瘤块植入NOD-SCID小鼠皮下和肝脏内，分别建立人肝癌皮下移植和原位移植模型。模拟临床肿瘤手术切除方法，切除皮下移植瘤和原位移植瘤，建立肝癌术后转移模型。观察肿瘤生长和动物的生存状况。通过病理解剖和组织病理学技术研究肿瘤在动物体内转移情况。
3．将人非小细胞肺癌NCI-H460组织块植入裸小鼠皮下，建立皮下移植瘤模型。4w后，25只裸小鼠作为手术组切除肿瘤组织，建立术后转移模型，15只裸小鼠作为对照组。每两周两组各处死5只动物动态观察其远处各脏器转移情况。动物明显消瘦时结束实验。采用免疫组化方法检测MMP-2、OPN、CD44v6、CD62等蛋白在转移灶及原发灶的表达情况。
4．用人胃癌MKN-45sci和MKN-45肿瘤组织块建立人胃癌原位移植动物模型，观察并比较两种模型的肿瘤生长和转移、血清肿瘤标志物及MMP-2、OPN、CD44v6、CD62与Timp-2的表达情况。取MKN-45sci肝转移灶形成的皮下移植瘤，用组织块法进行原代培养，建立MKN-45mc细胞株，观察肿瘤细胞的形态学、生长速度、体外侵袭能力、细胞周期变化，并与MKN-45细胞株进行比较。
三、结果
1．NOD-SCID小鼠人肝癌原位移植模型于5w可扪及肿瘤的生长，成瘤率为100％，11w肿瘤体积为(4.48±0.93)cm~3，瘤重为(7.02±1.15)g，肺部转移率为53.85％；裸小鼠人肝癌原位移植模型于6w～7w可扪及肿瘤的生长，成瘤率为100％，11w肿瘤体积为(1.02±0.70)cm~3，瘤重为(2.87±0.44)g，体内未见转移发生。NOD-SCID小鼠的瘤体积、瘤重、肺转移率均高于裸小鼠(P=0.000，P=0.000，P=0.011)。二者均保持AFP高分泌和γ-GT同工酶阳性的特性。
2．人肝癌HC-031皮下移植模型和原位移植模型由于肿瘤负荷过大分别于11w和6w而出现濒死状态，荷瘤平均生存时间为75d和44d。病理解剖，皮下移植瘤模型未发现转移(0／7)，原位移植瘤模型的肿瘤和邻近脏器侵袭明显，部分出现肺部转移(2／7)。皮下切瘤动物和肝原位切瘤动物分别于17w和12w出现恶病质现象，平均生存时间为154d和112d。病理解剖发现肺部均有肉眼可见癌性转移结节(7／7，7／7)。未切瘤动物和切瘤动物血清中AFP和γ-GTⅡ表达均为阳性。
3．人肺癌NCI-H460裸小鼠皮下移植瘤10w时瘤体严重坏死，并且动物出现明显消瘦，解剖未发现转移。手术组裸小鼠于10w、12w各发现一例肺转移(1／5)，14w时裸小鼠明显消瘦，肺转移率达100％(5／5)，有肉眼明显可见的肺转移结节，其他脏器未见转移。免疫组化结果表明，MMP-2、OPN、CD44v6、CD62和Timp-2在肺转移灶内的表达明显高于原发灶，CD54和MMP-9在转移灶内的表达则低于原发灶。
4．人胃癌原位移植模型MKN-45sci组动物的肝转移出现早且转移率高，4w左右肉眼即可看到肝转移结节(100％)，同时伴有淋巴结转移(100％)、肺转移(71％)、脾转移(29％)和腹水；移植瘤体积和重量明显增加，分别达到(3089±1617)mm~3和(2.66±1.32)g，动物出现恶病质。而4w时MKN-45组肝、肺、脾未见明显转移灶，仅2只动物有淋巴结转移；小鼠未见明显消瘦，移植瘤体积和重量为(275±90)mm~3和(0.35±0.14)g。MKN-45sci组血清中NSE和CYFRA21-1的浓度均较高，且随着肿瘤生长时间的延长而增高。而MKN-45组CYFRA21-1始终呈现阴性，4w时NSE仅为76.9 ng／ml。免疫组化结果显示MMP-9、OPN抗体在MKN-45sci组原位移植瘤和转移灶呈强阳性反应，而在MKN-45组原位移植瘤反应较弱。CD44v6抗体在MKN-45sci组原位移植瘤和转移灶呈阳性反应。E-cadherin抗体在MKN-45sci组原位移植瘤呈阳性反应，肝转移灶呈阴性反应。建立的MKN-45mc细胞株的染色体为超三倍体细胞，具有人类恶性肿瘤细胞染色体的特点。细胞形态为典型的上皮样细胞，与MKN-45的形态学特点相似。流式细胞分析显示MKN-45mc与MKN-45细胞周期各时相比例分别为：G_0-G_1期62.51％／53.95％，S期9.46％／1452％，G_2-M期28.04％／31.53％，两株细胞DNA合成期的细胞比例均较高。MKN-45mc与MKN-45细胞倍增时间分别为34.8h和42.1h，前者的生长速度高于后者。MKN-45mc与MKN-45的36h体外过膜数分别为(60.38±8.86)／高倍视野和(32.50±17.26)／高倍视野，前者多于后者。
四、结论
1．建立了与临床表现相似的人肝癌动物模型。与裸小鼠相比，NOD-SCID小鼠在建立人肝癌的异种移植模型方面有更大的应用价值。
2．模拟临床肿瘤切除方法，建立人肝癌术后转移动物模型。实验结果表明，荷瘤动物肿瘤切除后，生存期延长，有利于肿瘤转移发生。
3．裸小鼠人肺癌术后转移模型模拟了临床肿瘤根除术后发生远处转移的过程，结果提示肺癌转移的发生可能与部分粘附分子的异常表达相关，同时为研究肺癌转移机制和术后抗转移治疗提供理想的动物模型。
4．人胃癌原位移植动物模型体内筛选前后肿瘤的生物学特性不同，经筛选后肿瘤的生长和转移能力较未筛选的增强，其机理与肿瘤细胞粘附和降解能力得到强化有关。筛选后建立的细胞株生长速度、过膜能力比原细胞株增强，表明肿瘤转移与肿瘤细胞增殖和运动变形能力有关。
Metastasis is one of the most important biological characteristics on malignanttumor, and is the main cause of death for most cancer patients and thus is a majorobstacle to the successful treatment of such patients. Even if had tumour-reductivesurgery(TRS) for cancer patients, postoperative metastasis is the main obstruct thatimpact the curative effect of operation. The occurance and development of tumormetastasis is a complicated process of biological change finished by multiple factorsand steps. Therefore, it's necessary to generate the animal model of tumor metastasiswhich is close to the clinical condition for study of tumor metastasis. The animalmodel of human carcinoma xenotransplantation, established by transplanting humancarcinoma into nude mice, provides the possibility to investigate tumor deeply. Bothsubcutaneous implantation and orthotopic transplantation are two common methodsto produce these models. Due to obtain microenvironment the same as the situationsin human body, orthotopic transplantation is easier to express the malignant tumorbehavior. Thus, orthotopic transplantation is the main method to establish animalmodel of tumor metastasis.Liver cancer, gastric cancer and lung cancer, the prevalentcarcinoma, have representative significance if research on them.In this study, weobserved the difference of the biological characteristics in parasitifer on orthotopic into the subscutaneousness and liver of NOD-SCID mice. Then having TRS for tumorof subcutaneous implantation and orthotopic transplantation, we established a modelof postoperative metastasis of HCC by imitating clinical operation method. Weobserved the tumor growth and animal survival condition, and investigated metastasisin vivo by pathological anatomy and histopathology technology.
3. To establish the NCI-H460 subcutaneous metastasis model of nonsmall-celllung cancer (NSCLC) by using the histological intact tumor tissue. Four weeks later,40 nude mice were selected as operation group and had tumor resection to establishthe postoperative metastasis model at random. The rest were assigned to the controlgroup. Then five mice were sacrificed and dissected every two weeks to observe themetastasis in two groups. All of mice were sacrificed when animals were obviouslyslender, and subsequently detect the expression of MMP-2, OPN, CD44v6, CD62, etc,in metastases and primary tumor by immunohistochemistry (IHC).
4. We established orthotopic transplantation models of human gastric cancer innude mice using histologically intact tissue of MKN-45sci and MKN-45.The resultson growth, metastasis, markers in serum and expression of MMP-2, OPN, CD44v6,CD62 and Timp-2 of tumor in two models were observed. We established cell strainMKN-45mc, which was derived from a subcutaneous tumor that was grown into fromliver metastasis of MKN-45sci. We observed cell morphology, cell growth velocity,invasive power in vitro, change of cell cycle on cell strain MKN-45mc, and comparedwith strain MKN-45
Results:
1. The growth rate of the tumor was 100％in the orthotopic transplantationmodel of human hepatocellular carcinoma in NOD-SCID mice. The tumor inNOD-SCID mice was palpable at the 5th week. The volume, the weight and the lungmetastasis rate of the tumor was (4.48±0.93)cm~3, (7.02±1.15)g and 53.85％in NOD-SCID mice at the 11th week respectively. Growth rate of tumor was 100％inthe orthotopic transplantation model of human hepatocellular carcinoma in nude mice.The tumor was palpable between the 6th week and the 7th week. The volume, theweight of the tumor was(1.02±0.70)cm~3 and (2.87±0.44)g in nude mice at the 11thweek respectively, while no metastasis. The volume, the weight, the metastasis rate ofthe tumor in NOD-SCID mice were all significantly higher than those in nude mice(P=0.000, P=0.000, P=0.011). The two kinds of animals all kept the characteristics:highly secrete AFP highly and positiveγ-GTⅡ.
2. The models of subcutaneous implantation and orthotopic transplantation wereon the brink of death because of overload of tumor at the 11th and 6th week,separately. The average survival time of the two kinds of models is 75d and 44drespectively. By pathological anatomy, metastasis (0/7) was not observed in model ofsubcutaneous implantation. Metastasis in lung (2/7) was observed in the model oforthotopic transplantation and the tumor obviouslly invaded the adjacent organs. Theanimals after TRS to the model of subcutaneous implantation and orthotopictransplantation were on the brink of death at the 17w and 12w respectively. Theaverage survival time of them is 75d and 44d, respectively. Metastasis nodes in lungcould be found with naked eyes (7/7,7/7). The expression of AFP andγ-GTⅡin theserum of animals via both resection and non-resection was positive.
3. Mice in control group, non-metastasis in each stage, were the expression ofobvious emaciation and tumor necrosis after 10 weeks. While in the operation group,the metastasis rate was 20％(1/5) in lung when mice were sacrificed at 10 and 12weeks. The metastasis rate was 100％(5/5) in lung when the mice were sacrificed at14 weeks with non-metastasis in other organs. The IHC results indicate that theexpression of MMP-2, OPN, CD44v6, CD62 and Timp-2 in metastases were higherthan in primary tumor, while the expression of CD54 and MMP-9 in metastases were lower than that in primary tumor.
4. The metastasis in liver in MKN-45sci group was earlier occurrence and higherpercentage. At the 4th week, the metastasis percentage in liver, lymphonode, lung,spleen and abdominal dropsy is 100％, 100％, 71％, 29％and 29％, respectively. Thevolume and weight of transplantation tumor obviously increased to (3089+1617)mm~3and (2.66±1.32)g. The cachexia occurred to the animal in MKN-45sci group at the4th week. Whereas the metastasis in liver, lung and spleen in MKN-45 group was notobvious at the same time other than lymphonode in two mice. The volume and weightof transplantation tumor were (275±90)mm~3 and (0.35±0.14)g. The animal inMKN-45 group was not obvious emaciation. The density of NSE and CYFRA21-1 inserum in MKN-45sci group was much greater, which could enhance with theprolongation of the time that tumor grew. But CYFRA21-1 in MKN-45 group wasnegative all the time, and NSE was merely 76.9ng/ml at the 4th week. The IHCresults indicated, the expression of MMP-9 and OPN was higher in transplantationtumor and metastasis in MKN-45sci group, but lower in transplantation tumor inMKN-45 group; CD44v6 in transplantation tumor and metastasis in MKN-45sci ispositive; the expression of E-cadherin in MKN-45sci was deteced in orthotopictransplantation tumor, and not tested in metastasis in liver. The chromosome of cellstrain MKN-45mc established embodied the characteristics of that of humammalignant tumor cell, which was hypertriploid. Its characteristics of cell morphologywas similar to MKN-45, which was typical epitheliod cell. The phase proportion ofcell circle of MKN-45mc and MKN-45 was 62.51％/53.95％in G_0-G_1, 9.46％/14.52％in S, 28.04％/31.53％in G_2-M respectively via flow cytometry. The cell quantity oftwo cell strains was more greater in DNA synthesis phase. The cell growth velocity ofMKN-45mc was higher than that of MKN-45, whose double time was 34.8h and42.1h. The number of cell penetrating through membrane in MKN-45mc was greater than that in MKN-45 in 36 hours, which was (60.38±8.86) and (32.50±17.26) inhighpower field.
Conclusion:
1. We have established the animal model of HCC that is similar to the clinic. Theapplication significance in NOD-SCID mice is greater than that in nude mice as far asestablishing xenotransplantation model of HCC.
2. We establish animal model of postoperative metastasis of human HCC byTRS in clinic. The results show that resection is easier to the development ofmetastasis in the animal bodies bearing cancer due to prolongation of life span.
3. This animal model simulates the metastasis after clinical operation, and theIHC results indicated that metastasis is in correlation with some adhesion molecules.This kind of model provides valuable data to study mechanism of NSCLC metastasisand treatment of human NSCLC.
4. The biological characteristics on orthotopic transplantation models of humangastric cancer in animal is different after filtration or non-filtration.The capability oftumor growth and metastasis which has been filtered is greater than which not filtered,which mechanism could be associated with strengthening adhesion and degradationof tumor cells. The growth velocity and invasive power in vitro of the cell strainwhich has been filtered is greater than the cell strain which not filtered, whichindicates that the ability of cell metastasis has relationship with the ability of cellmultiplication and metamorphosis.
引文
[1] Aznavoorian S, Murphy AN, Stetler-Stevenson WG, et al. Molecular aspect of tumor cell invasion and metastasis[J]. Cancer, 1993, 71: 1368-83
[2] Liotta LA, Rao CN, Barsky SH. Tumor invasion and the extracellular matrix[J]. Lab invest, 1983, 49(6): 636-49
[3] 高进．动物肿瘤模型的建立及其标准研讨[J]．中国肿瘤生物治疗杂志，1995，2(1)：76-79
[4] Wang JC, Lapidot T, Cashman JD, et al. High level engraftment of NOD/SCID mice by primitive normal and leukemia hematopoietic cells from patients with chronic myeloid leukemia in chronic phase[J]. Blood, 1998, 91:2406-2414
[5] 姚明，闫明霞，周光兴，等．BNX小鼠人胃癌原位移植模型的建立及其生物学特性的观察[J]．肿瘤，2004，24(6)：566-569
[6] Fu X, Hoffman RM. Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically intact patient specimens[J]. Anticancer Res, 1993, 13(2): 283-6
[7] Fidler IJ. Critical factors in the biology of human cancer metastasis[J]. Cancer Res, 1990, 50:6130-6138
[8] Manzotti C, Audisio RA, Pratesi G.Importance of orthotopic implantation forhuman tumors as model systems: revelance to metastasis and invasion[J]. Clin Exp Metatasis, 1993, 11:5-14
[9] 高进．癌细胞转移模型的建立及应用．见：高进，章静波主编．癌的侵袭与转移基础与临床．北京：科学出版社，2003，5
[10] Sharkey FE and Fogh J. Considerations in the use of nude mice for cancer research. Cancer Metastasis Reviews, 1984, 3:341-360
[11] Fidler IJ. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Reviews, 1986, 5: 29-49
[12] Zhou XD, Tang ZY, Yu XQ, et al. Recurrence after resection of alpha-fetoprotein positive hepatocellular carcinoma[J]. J Cancr Res Clin Oncol, 1994, 120: 369-373
[13] Tang ZY, Yang BH. Secondary prevention of hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 1995, 10(6): 683-90
[14] 王文萍，贾立群．肺肿瘤的转移．见：王文萍主编．实用肿瘤转移学．沈阳：辽宁科学技术出版社，2003，3
[1] 刘少杰，沈文律．荷人肝癌裸小鼠模型在原发性肝癌研究中的应用[J]．汕头大学医学院学报，2004，17(3)：187-189
[2] 刘锡忠，胡敬群，崔惠云，等．人肝癌裸小鼠模型的建立及其生物学特性的研究[J]．中国医学科学院学报，1995，17(2)：98-103
[3] Sun FX, Tang ZY, Liu KD, et al. Establismhment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues[J], lnt J Cancer, 1996, 66:239-243
[4] 郑建明，陶文照，郑唯强，等．人肝癌裸鼠皮下-肝原位移植瘤模型的建立[J]．第二军医大学学报，2000，21(5)：456-459
[5] 郜永顺，陈孝平，李开艳，等．保持人肝癌生物学特性的人肝癌组织裸鼠肝内种植模型的建立[J]．中华普通外科杂志，2004，19(8)：468-470
[6] 汤钊猷．肝癌研究进展[J]．中国肿瘤，2001，10(1)：37-40
[7] Aznavoorian S, Murphy AN, Stetler-Stevenson WG, et al. Molecular aspect of tumor cell invasion and metastasis[J]. Cancer 1993, 71:1368-1385
[8] 汤钊猷，陈军，高东梅，等．裸鼠人体肝癌移植模型的研究．模型的建立及其血清学与形态学特征[J]．上海第一医学院学报，1989，9：21-24
[9] Wang JC, Lapidot T, Cashman JD, et al. High level engraftment of NOD/SCID mice by primitive normal and leukemia hematopoietic cells from patients with chronic myeloid leukemia in chronic phase[J]. Blood, 1998, 91:2406-2414
[10] 姚明，闫明霞，周光兴，等．BNX小鼠人胃癌原位移植模型的建立及其生物学特性的观察[J]．肿瘤，2004，24(6)：566-569
[11] 陶文照，郑唯强，龚志锦．人肝癌组织裸鼠腹腔内和肝正位移植显示的肿瘤侵袭与转移[J]．第二军医大学学报，1998，19(1)：54-56
[12] 李雁，汤钊猷，叶胜龙，等．体内连续筛选法建立自发性肺转移人肝癌细胞系[J]．中华医学杂志，2002，82(9)：601-605
[1] Tang ZY, Yu XQ, Zhou XD, et al. Progress and prospects in hepatocellular carcinoma surgery[J]. Ann Chir, 1998, 52(6): 558-563
[2] Zhou XD, Tang ZY, Yu XQ, et al. Recurrence after resection of alpha-fetoprotein positive hepatocellular carcinoma[J]. J Cancr Res Clin Oncol, 1994, 120: 369-373
[3] Tang ZY, Yang BH. Secondary prevention of hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 1995, 10(6): 683-90
[4] Robert S, Chukwumere EN, Mathijs JB, etal. The surgical management of pulmonary metastasis: currentconcept[J]. SurgOncol, 2001, 10(1-2): 35-42
[5] Kakumu S. Trends in liver cancer researched by the Liver Cancer Study Group of Japan[J]. Hepatol Res, 2002, 24(Suppl): 21-27
[6] Ikai I, Itai Y, Okita K. Report of the 15th follow-up survey of primary liver cancer[J]. Hepatol Res, 2004, 28(1): 21-29
[7] 张树民，曾昭冲，孙菁，等．肝细胞肝癌肺转移的预后因素分析[J]．实用肿瘤杂志，2005，20(5)：395-400
[8] 汤钊猷，陈军，高东梅，等．裸鼠人体肝癌移植模型的研究．模型的建立及其血清学与形态学特征[J]．上海第一医学院学报，1989，9：21-24
[9] 孙昉宪，汤钊猷，刘康达，等．裸鼠人肝癌原位移植模型的生长特性及转移潜能[J]．中华医学杂志，1995，75(11)：673-675
[10] Cillo U, Vitale A, Bassanello M, et al. Liver transplantation for treatment of moderately or well-differentiated hepatocellular carcinoma[J]. Ann Surg, 2004, 239:150-159
[1] 王志瑾．肺癌流行病学[J]．肿瘤防治杂志，2002，9(1)：1-5
[2] 姚明，孔韩卫，戚锦芳等．人黑色素瘤SCID小鼠高转移模型的筛选和建立[J]．上海实验动物科学，2001，21(4)：195-199
[3] Haruhiko I, Takuya Y, Hanako S, et al. Enhancement ofpleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs). Lung Cancer, 2004,45: 325-337
[4] 廖美琳．肺癌[M]．北京：中国医药科技出版社，2003．399
[5] 白春学，张新．肺癌的治疗现状[J]．中华结核和呼吸杂志．2006，29(3)：146-148
[6] 吴炜新，王冠军，陈晓等．人肺巨细胞癌PLA-801C和PLA-801D的体内自发转移性再研究．中国实验诊断学．2005，9(2)：194-197
[7] Michael McLean, Howard L. Wallace, Atima Sharmal, et al. A BALB/c murine lung alveolar carcinoma used to establish a surgical spontaneous metastasis model[J]. Clinical & Experimental Metastasis, 2004, 21:363-369
[8] Eiji Tanaka, MD; Jun-ichi Yamashita, MD; Naoko Hayashi, MD; et al. A Pulmonary Metastatic Model of Human Non-small Cell Lung Carcinoma Cells That Produce a Neutrophil Elastase-Like Molecule in Severe Combined Immunodeficiency Mice[J]. Chest, 2003, 123:1248-1253
[9] Tanja Schneider, Franz Osl, Thomas Friess, et al. Quantification of human Alu sequences by real-time PCR-an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants[J]. Clinical & Experimental Metastasis, 2002, 19:571-582
[10] 吴秉铨，孙毓恺，郑杰等．裸鼠体内建立的人类高转移癌系[J]．中华肿瘤杂志，1985，7(5)：324
[11] Morikawa K, Walker SM, Nakjima M, et al. Influence of organen vironment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice [J]. Cancer Res, 1988, 48(23): 6863
[12] 张申，魏品康，何金，等．金龙蛇方对人胃癌MKN-45裸小鼠原位移植瘤生长转移及多种粘附分子蛋白表达的影响[J]．肿瘤．2006，26(6)：519-524
[13] Urbanski S J, Edwards DR, Maitland A, et al. Expression of metalloproteinase and their inhibitors in primary pulmonary carcinomas. Br J Cancer, 1992, 66(6): 1188-1194
[14] 王新允，杨菊红，马莹，等．肺癌MMPs和TIMPs的表达及浸润转移的研究[J]．中国肺癌杂志，2003，6(4)：278-282
[15] AGRAWAL D, CHEN T, IRBY R, et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling[J]. J Natl Cancer Inst, 2002, 94:513-521
[16] Gao C, Guo H, Downey L, et al. Osteopontin-dependent CD44v6 expression and cell adhesion in Hepg2 cells[J]. Carcinogenesis, 2003, 24(12): 1871-1878
[17] Hefler LA, Concin N, Mincham D, et al. The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma: a multicenter study[J]. Cancer, 2002, 94(1): 125-130
[18] 宋兰英，闫文生，张进华，等．粘附分子CD54、CD44v6在肺癌转移中的作用[J]．实用癌症杂志，2003，18(1)：54-55
[19] 毛梅，杨炯．基质金属蛋白酶在肺癌组织中的表达及临床意义[J]．中国肿瘤临床与康复，2003，2(10)：97-99
[1] Isaiah J.Fidler. Critical determinants of metastasis[J]. Cancer Biology, 2002, 12: 89-96
[2] 闫明霞，姚明，许兰文，等．裸小鼠人胃癌肝转移模型的筛选和建立[J]．上海实验动物科学，2005，25(2)：1-5
[3] Ogawa K, Nakanishi H, Takeshita F, et al. Establishment of rat hepatocellular carcinoma cell lines with differing metastatic potential in nude mice [J]. Int J Cancer, 2001, 91(6): 797-802
[4] Li Y, Tian B, Yang J, et al. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics[J]. J Cancer Res Clin Oncol, 2004, 130(8): 460-468
[5] Isaiah J. Fidler. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. clowes memorial award lecture [J]. Cancer Research, 1990, 50:6130-6138
[6] 姚明，孔韩卫，戚锦芳，等．人黑色素瘤SCID小鼠高转移模型的筛选和建立[J]．上海实验动物科学，2001，21(4)：195-199
[7] Li Y, Tang Z, Ye S, et al. Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection [J]. Chung-Hua i Hsueh Tsa Chih, 2002, 82(9): 601-605
[8] Yamaguchi K, Ura H, Yasoshima T, et al. Liver metastatic model for human gastric cancer established by orthotopic tumor cell implantation[J]. World Journal of Surgery, 2001, 25(2): 131-137
[9] Parsons SL, Watson SA, Brown PO. Matrix metalloproteinase[J]. Br J Surg, 1997, 84:160-166
[10] Iiabakk NB, Talbot L, Smith RA, et al. Matrix metalloproteinase 1(MMP1) and matrix metalloproteinase 9(MMP9), type IV colleagenase in colorectal cancer[J]. Cancer Res, 1996, 56:190-196
[11]Denhardt DT, Giachelli CM, Rittling SR. Role of Osteopontin in celluar signaling ang toxicant injurv[J]. Annu Rev Pharmacol Toxicol, 2001, 41: 723-749
[12] Tuck AB, Malley FP, Singhal H, et al. Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas[J]. Arch Pathol Lab Med, 1997, 121(6): 578-584
[13] Isaiah J. F idler. Critical factors in the biology of human cancer metastasis: Twenty-eighth G. H. A. Clowes Memorial Lecture [J]. Cancer Res, 1990, 50: 6130-6138
[14] Isaiah J. Fidler. Critical determinants of metastasis [J]. Cancer Biology, 2002, 12: 89-96
[15] Price JE. Influence of organ environment on metastasis [J]. Cancer Bull, 1987, 39(3): 162-167
[16] Repesh LA. A new in vitro assay for quantitating tumor cell invasion[J]. Invasion Metastasis. 1989, 9(3): 192-208
[17] Terranova VP, Hujanen ES,Loeb DM, et al. Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cell[J]. Proc Natl Acad Sci USA. 1986, 83(2): 465-469
[18] Jacob K, Webber M, Benayahu D, et al. Osteonectin promotesprostate cancer cell migration and invasion: a possible mechanisnism for metastasis to bone[J]. Cancer Res, 1999, 59 (17): 4453-4457
[19] Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis [J]. Nature, 2001, 410(6824): 50-56
[20] Gutman M, Singh RK, Xie K, et al. Regulation of IL-8expression in human melanoma cells by the organ environment[J]. Cancer Res, 1995, 55(11): 2470-2475
[21] 冀学宁，叶胜龙，李雁，等．肺组织粗提物促进人原发性肝癌细胞移动侵袭的研究[J]．中华实验外科杂志，2003，20(3)：219-220
[1] Tang ZY.Hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2000, 15(suppl): G1
[2] Sun FX, Tang ZY, Liu KD, et al. Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues[J]. Int Jcancer, 1996, 66:239-243
[3] Tian J, Tang ZY, Ye SL, et al. New human hepatocelluar carcinoma(HCC) cell line with highly metastatic potencial(MHCC97) and its expressions of the factors associated with metastasis [J]. Br J Cancer, 1999, 81: 814-821
[4] 郑建明，陶文照，郑唯强，等．人肝癌裸鼠皮下-肝原位种植瘤模型的建立[J]．第二军医大学学报，2000，21：456-459
[5] 郜永顺，陈孝平，李开艳，等．保持人肝癌生物学特性的人肝癌组织裸鼠肝内种植模型的建立[J]．中华普通外科杂志，2004，19(8)：468-470
[6] 刘虎，叶胜龙，薛琼，等．大鼠肝癌自发肺转移裸鼠模型的建立[J]．中华实验外科杂志，2004，21(1)：101-102
[7] 徐冰，姚明，闫明霞，等．人肝癌NOD-SCID小鼠原位移植模型的建立及其生物学特性的研究[J]．肿瘤，2006，26(11)：975-978
[8] 姚英民，刘青光，扬威，等．肝癌合并肝硬化时脾脏对机体免疫状态影响的实验研究[J]．中华肝胆外科杂志，2002，8(7)：428-430
[9] 顾伟，沈婕，翟笑枫．大鼠移植性肝癌模型生物学行为与分期的初步探讨[J]．中西医结合学报，2005，3(2)：136-138
[10] 蔡萍，张琳，丁仕义，等．兔VX2肝移植癌模型的建立及CT评价[J]．第三军医大学学报，2004，26(21)：1924-1927
[11] 杜文华，杨未晓，熊秀勤，等．兔转移性肝癌血管超声声学造影的实验研究[J]．重庆医学，2003，32(7)：873-875
[12] 唐浩，梁平．外周血GPC-3 mRNA在大鼠肝癌微转移中的意义[J]．消化外科，2005，4(1)：48-51
[13] 吴晓凤，林芷英，樊嘉，等．外周血甲胎蛋白mRNA定量与裸鼠肝癌术后复发转移的关系[J]．中华肝脏病杂志，2002，10(3)：189-192
[14] 李琦，孟庆莉，彭永海，等．大鼠移植性肝癌模型的制作．第二军医大学学报[J]，2002，23：1074
[15] 金昌德，施新猷，仇凯．转染pG基因HHCC细胞的裸鼠转移模型的复制[J]．中国兽医科技，2000，30(6)：15-17
[16] 师长宏，王晓武，王文勇，等．人肝癌原位移植转移模型特性实验研究[J]．中国实验动物学报，2001，9(1)：55-61
[17] 李雁，汤钊猷，叶胜龙，等．不同转移潜能人肝癌单克隆细胞株的分离和建立[J]．中华肝胆外科杂志，2001，7(11)：681-685
[18] 李雁，汤钊猷，叶胜龙，等．体内连续筛选法建立自发性肺转移人肝癌细胞系[J]．中华医学杂志，2002，82(9)：601-605
[19] 高进．癌细胞转移模型的建立及应用．见：高进，章静波主编．癌的侵袭及转移基础与临床．第1版，北京：科学出版社，2003，5
[20] Zeng JZ, Wang HY, Chen ZJ, et al. Molecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma[J]. Oncogene, 2002, 21 (32): 4932-4943
[21] Wang XW, Hussain SP, Huo TI, et al. Molecular pathogenesis of human hepatocellular carcinoma[J]. Toxicology, 2002, 12 (181-182): 43-7
[22] Uchida T, Gao JP, Wang CX, et al. Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma[J]. Urology, 2002, 59(4): 615-20
[23] Capurro MI, Xiang YY, Lobe C, Filmus J. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling[J]. Cancer Res 2005, 65:6245-6254
[24] Sung YK, Hwang SY, Park MK, et al. GLYpican-3 is over expressed in human hepatocellular carcinoma[J]. Cancer Sci, 2003, 94(3): 259-262
[25] Midorikawa Y, Ishikawa S, Iwanari H, et al. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling[J]. Int J Cancer, 2003, 103(4): 455-465
[26] 罗洪英，王海成，冯德云，等．肝细胞癌组织中PCNA和nm23的表达与转移的关系[J]．湖南医科大学学报，2003，28(1)：17
[27] Endo K, Ueda T, Ueyama J, et al.Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationship with tumor grade, clinicopathologic parameters, and patients survival[J]. Hum Patol, 2000, 31(5): 558-565
[28] 张宝华，陈汉．E-选择素及其配体Slex在肝癌转移中的意义[J]．中华外科杂志，2000，38(7)：534-536
[29] 朱继红，刘丽萍，童蓓燕，等．肝癌发生与转移过程中E-选择素在裸鼠肝、 肺、肾微血管内皮细胞的表达[J]．解剖学杂志，2001，24(3)：269-272
[30] Fawn Qi, Hanahan D, Weissman IL. L-selectin can facilitate metastasis to lymph nodes in a transgeninc mouse model of carnogenesis[J]. Proc Natl Acad Sci USA, 2001,98(7): 3976-3981
[31] 刘敏，王莉芬，朱杰，等．L-选择蛋白可能介导小鼠肝癌HCa-F细胞经淋巴道转移的研究[J]．解剖学报，2004，35(5)：502-508
[32] Torimura T, Ueno T, Kin M, et al. Lamininin deposition to type Ⅳ collagen enhances haptotaxis,chemokinesis, and adhesion of hepatoma cells through betal-integrins[J]. J Hepatol, 2001, 35(2): 245-253
[33] Carloni V, Mazzocca A, Pantaleo P, et al. The integrin, alpha6betall, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocacinoma cells [J]. Hepatology, 2001, 34(1): 42-49
[34] Xu Z, Shen MX, Ma DZ, et al. TGF-tetall promoted epithelial to mesenchymal transformation and cell adhesion contribute to TGF-betall enhenced cell migration in SMMC-7721 cells[J]. Cell Res, 2003, 3(5): 343-350
[35] 韦长元，李挺，刘剑仑，等．Ⅰ型细胞间黏附分子与肝癌侵袭转移的关系[J]．肝胆外科杂志，2001，9(1)：57-58
[36] 徐斌，居小萍，张晓华，等．细胞黏附分子在肝细胞癌发生及转移中的作用[J]．中华肝胆外科杂志，2002，8(7)：405-407
[37] 官成浓，杨丰，银正民，等．原发性肝癌患者血清可溶性细胞间黏附分子1的测定及其临床意义[J]．实用癌症杂志，2002，17(2)：164-166
[38] Endo K, Terade T. Protein expression of CD44(standard andvariant isoforms) in hepatocellular carcimoma: relationships with tumor grade, clinicopathologic parameters, p53 expression and patient survival[J]. J Hepatol, 2000, 32(1): 78-84
[39] NIETO-RODRIGUEZ A, HERNANADEZ-PANDO R, KERSHENOBICH D, et al. Expression of urokinase-type plas minogen activator in an experimental model of hepatocarcinoma[J]. Toxicology, 2001, 161 (1-2): 13-23
[40] Zheng Q, Tang ZY, Xue Q, et al. Invasion and metastasis of hepatocellular carcinoma in relation to urkinase-type plasminogen activator, its receptor and inhibitor[J]. J Cancer Res Clin Oncol, 2000, 126(11): 641-646
[41] 侯振江，张宗英．基质金属蛋白酶系统与恶性肿瘤[J]．国外医学临床生物化学与检验学分册，2004，25(1)：83-85
[42] Bodey B, Bodey B Jr, Siegel SE, et al. Immunocytochemical detction of MMP3 and 10 expression in hepatocellular carcinoma[J]. Anticancer Res, 2000, 20(6B): 4585-4590
[43] Sela BA. Matrix metalloproteinases: promoters of tumor progression and invasiveness. Isr Med Assoc [J]. 2002,4(4): 280-282
[44] 朱争艳，杜智，王毅军，等．钙粘素E和基质金属蛋白酶检测与肝癌预后关系研究[J]．临床肝胆病杂志，2002，18(4)：235-236
[45] 彭利，王顺祥，张风瑞，等．基质金属蛋白酶9和血管内皮生长因子与原发性肝癌侵袭转移关系研究[J]．中华肝胆外科杂志，2003，9(1)：42-44
[46] Park YN, Kin YB, Yang KM, et al. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogensis[J]. Arch Pathol Lab Med, 2000, 124(7): 1061-1065
[47] Poon RT, Ng IO, Lau C, et al. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma:a prospective study[J]. Ann Surg, 2001, 233(2): 227-235
[48] IGUCHI H, YOKOTA M, FUKUTOMI M, et al. A possible role of VEGF in osteolytic bone metastasis of hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2002, 21(3): 309-313
[49] 邓伟，梁力建．血管生成素和VEGF在人肝细胞癌血管生成作用机制的研究[J]．中国普通外科杂志，2005，14(6)：436-440
[50] Moon WS, Rhyu KH, Kang MJ, et al. Overexpression of VEGF and angiopoietin2: a key to high vascularity of hepatocellular carcinoma[J]. Mod Pathol, 2003, 16(6): 552-557
[51] Yoshiji H, Kuriyama S, Yoshii J, et al. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma[J]. Hepatology, 2002, 35: 834-842
[2] Liotta LA, Rao CN, Barsky SH. Tumor invasion and the extracellular matrix[J]. Lab invest, 1983, 49(6): 636-49
[3] 高进．动物肿瘤模型的建立及其标准研讨[J]．中国肿瘤生物治疗杂志，1995，2(1)：76-79
[4] Wang JC, Lapidot T, Cashman JD, et al. High level engraftment of NOD/SCID mice by primitive normal and leukemia hematopoietic cells from patients with chronic myeloid leukemia in chronic phase[J]. Blood, 1998, 91:2406-2414
[5] 姚明，闫明霞，周光兴，等．BNX小鼠人胃癌原位移植模型的建立及其生物学特性的观察[J]．肿瘤，2004，24(6)：566-569
[6] Fu X, Hoffman RM. Human ovarian carcinoma metastatic models constructed in nude mice by orthotopic transplantation of histologically intact patient specimens[J]. Anticancer Res, 1993, 13(2): 283-6
[7] Fidler IJ. Critical factors in the biology of human cancer metastasis[J]. Cancer Res, 1990, 50:6130-6138
[8] Manzotti C, Audisio RA, Pratesi G.Importance of orthotopic implantation forhuman tumors as model systems: revelance to metastasis and invasion[J]. Clin Exp Metatasis, 1993, 11:5-14
[9] 高进．癌细胞转移模型的建立及应用．见：高进，章静波主编．癌的侵袭与转移基础与临床．北京：科学出版社，2003，5
[10] Sharkey FE and Fogh J. Considerations in the use of nude mice for cancer research. Cancer Metastasis Reviews, 1984, 3:341-360
[11] Fidler IJ. Rationale and methods for the use of nude mice to study the biology and therapy of human cancer metastasis. Cancer Metastasis Reviews, 1986, 5: 29-49
[12] Zhou XD, Tang ZY, Yu XQ, et al. Recurrence after resection of alpha-fetoprotein positive hepatocellular carcinoma[J]. J Cancr Res Clin Oncol, 1994, 120: 369-373
[13] Tang ZY, Yang BH. Secondary prevention of hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 1995, 10(6): 683-90
[14] 王文萍，贾立群．肺肿瘤的转移．见：王文萍主编．实用肿瘤转移学．沈阳：辽宁科学技术出版社，2003，3
[1] 刘少杰，沈文律．荷人肝癌裸小鼠模型在原发性肝癌研究中的应用[J]．汕头大学医学院学报，2004，17(3)：187-189
[2] 刘锡忠，胡敬群，崔惠云，等．人肝癌裸小鼠模型的建立及其生物学特性的研究[J]．中国医学科学院学报，1995，17(2)：98-103
[3] Sun FX, Tang ZY, Liu KD, et al. Establismhment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues[J], lnt J Cancer, 1996, 66:239-243
[4] 郑建明，陶文照，郑唯强，等．人肝癌裸鼠皮下-肝原位移植瘤模型的建立[J]．第二军医大学学报，2000，21(5)：456-459
[5] 郜永顺，陈孝平，李开艳，等．保持人肝癌生物学特性的人肝癌组织裸鼠肝内种植模型的建立[J]．中华普通外科杂志，2004，19(8)：468-470
[6] 汤钊猷．肝癌研究进展[J]．中国肿瘤，2001，10(1)：37-40
[7] Aznavoorian S, Murphy AN, Stetler-Stevenson WG, et al. Molecular aspect of tumor cell invasion and metastasis[J]. Cancer 1993, 71:1368-1385
[8] 汤钊猷，陈军，高东梅，等．裸鼠人体肝癌移植模型的研究．模型的建立及其血清学与形态学特征[J]．上海第一医学院学报，1989，9：21-24
[9] Wang JC, Lapidot T, Cashman JD, et al. High level engraftment of NOD/SCID mice by primitive normal and leukemia hematopoietic cells from patients with chronic myeloid leukemia in chronic phase[J]. Blood, 1998, 91:2406-2414
[10] 姚明，闫明霞，周光兴，等．BNX小鼠人胃癌原位移植模型的建立及其生物学特性的观察[J]．肿瘤，2004，24(6)：566-569
[11] 陶文照，郑唯强，龚志锦．人肝癌组织裸鼠腹腔内和肝正位移植显示的肿瘤侵袭与转移[J]．第二军医大学学报，1998，19(1)：54-56
[12] 李雁，汤钊猷，叶胜龙，等．体内连续筛选法建立自发性肺转移人肝癌细胞系[J]．中华医学杂志，2002，82(9)：601-605
[1] Tang ZY, Yu XQ, Zhou XD, et al. Progress and prospects in hepatocellular carcinoma surgery[J]. Ann Chir, 1998, 52(6): 558-563
[2] Zhou XD, Tang ZY, Yu XQ, et al. Recurrence after resection of alpha-fetoprotein positive hepatocellular carcinoma[J]. J Cancr Res Clin Oncol, 1994, 120: 369-373
[3] Tang ZY, Yang BH. Secondary prevention of hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 1995, 10(6): 683-90
[4] Robert S, Chukwumere EN, Mathijs JB, etal. The surgical management of pulmonary metastasis: currentconcept[J]. SurgOncol, 2001, 10(1-2): 35-42
[5] Kakumu S. Trends in liver cancer researched by the Liver Cancer Study Group of Japan[J]. Hepatol Res, 2002, 24(Suppl): 21-27
[6] Ikai I, Itai Y, Okita K. Report of the 15th follow-up survey of primary liver cancer[J]. Hepatol Res, 2004, 28(1): 21-29
[7] 张树民，曾昭冲，孙菁，等．肝细胞肝癌肺转移的预后因素分析[J]．实用肿瘤杂志，2005，20(5)：395-400
[8] 汤钊猷，陈军，高东梅，等．裸鼠人体肝癌移植模型的研究．模型的建立及其血清学与形态学特征[J]．上海第一医学院学报，1989，9：21-24
[9] 孙昉宪，汤钊猷，刘康达，等．裸鼠人肝癌原位移植模型的生长特性及转移潜能[J]．中华医学杂志，1995，75(11)：673-675
[10] Cillo U, Vitale A, Bassanello M, et al. Liver transplantation for treatment of moderately or well-differentiated hepatocellular carcinoma[J]. Ann Surg, 2004, 239:150-159
[1] 王志瑾．肺癌流行病学[J]．肿瘤防治杂志，2002，9(1)：1-5
[2] 姚明，孔韩卫，戚锦芳等．人黑色素瘤SCID小鼠高转移模型的筛选和建立[J]．上海实验动物科学，2001，21(4)：195-199
[3] Haruhiko I, Takuya Y, Hanako S, et al. Enhancement ofpleural dissemination and lymph node metastasis of intrathoracic lung cancer cells by vascular endothelial growth factors (VEGFs). Lung Cancer, 2004,45: 325-337
[4] 廖美琳．肺癌[M]．北京：中国医药科技出版社，2003．399
[5] 白春学，张新．肺癌的治疗现状[J]．中华结核和呼吸杂志．2006，29(3)：146-148
[6] 吴炜新，王冠军，陈晓等．人肺巨细胞癌PLA-801C和PLA-801D的体内自发转移性再研究．中国实验诊断学．2005，9(2)：194-197
[7] Michael McLean, Howard L. Wallace, Atima Sharmal, et al. A BALB/c murine lung alveolar carcinoma used to establish a surgical spontaneous metastasis model[J]. Clinical & Experimental Metastasis, 2004, 21:363-369
[8] Eiji Tanaka, MD; Jun-ichi Yamashita, MD; Naoko Hayashi, MD; et al. A Pulmonary Metastatic Model of Human Non-small Cell Lung Carcinoma Cells That Produce a Neutrophil Elastase-Like Molecule in Severe Combined Immunodeficiency Mice[J]. Chest, 2003, 123:1248-1253
[9] Tanja Schneider, Franz Osl, Thomas Friess, et al. Quantification of human Alu sequences by real-time PCR-an improved method to measure therapeutic efficacy of anti-metastatic drugs in human xenotransplants[J]. Clinical & Experimental Metastasis, 2002, 19:571-582
[10] 吴秉铨，孙毓恺，郑杰等．裸鼠体内建立的人类高转移癌系[J]．中华肿瘤杂志，1985，7(5)：324
[11] Morikawa K, Walker SM, Nakjima M, et al. Influence of organen vironment on the growth, selection, and metastasis of human colon carcinoma cells in nude mice [J]. Cancer Res, 1988, 48(23): 6863
[12] 张申，魏品康，何金，等．金龙蛇方对人胃癌MKN-45裸小鼠原位移植瘤生长转移及多种粘附分子蛋白表达的影响[J]．肿瘤．2006，26(6)：519-524
[13] Urbanski S J, Edwards DR, Maitland A, et al. Expression of metalloproteinase and their inhibitors in primary pulmonary carcinomas. Br J Cancer, 1992, 66(6): 1188-1194
[14] 王新允，杨菊红，马莹，等．肺癌MMPs和TIMPs的表达及浸润转移的研究[J]．中国肺癌杂志，2003，6(4)：278-282
[15] AGRAWAL D, CHEN T, IRBY R, et al. Osteopontin identified as lead marker of colon cancer progression, using pooled sample expression profiling[J]. J Natl Cancer Inst, 2002, 94:513-521
[16] Gao C, Guo H, Downey L, et al. Osteopontin-dependent CD44v6 expression and cell adhesion in Hepg2 cells[J]. Carcinogenesis, 2003, 24(12): 1871-1878
[17] Hefler LA, Concin N, Mincham D, et al. The prognostic value of immunohistochemically detected CD44v3 and CD44v6 expression in patients with surgically staged vulvar carcinoma: a multicenter study[J]. Cancer, 2002, 94(1): 125-130
[18] 宋兰英，闫文生，张进华，等．粘附分子CD54、CD44v6在肺癌转移中的作用[J]．实用癌症杂志，2003，18(1)：54-55
[19] 毛梅，杨炯．基质金属蛋白酶在肺癌组织中的表达及临床意义[J]．中国肿瘤临床与康复，2003，2(10)：97-99
[1] Isaiah J.Fidler. Critical determinants of metastasis[J]. Cancer Biology, 2002, 12: 89-96
[2] 闫明霞，姚明，许兰文，等．裸小鼠人胃癌肝转移模型的筛选和建立[J]．上海实验动物科学，2005，25(2)：1-5
[3] Ogawa K, Nakanishi H, Takeshita F, et al. Establishment of rat hepatocellular carcinoma cell lines with differing metastatic potential in nude mice [J]. Int J Cancer, 2001, 91(6): 797-802
[4] Li Y, Tian B, Yang J, et al. Stepwise metastatic human hepatocellular carcinoma cell model system with multiple metastatic potentials established through consecutive in vivo selection and studies on metastatic characteristics[J]. J Cancer Res Clin Oncol, 2004, 130(8): 460-468
[5] Isaiah J. Fidler. Critical factors in the biology of human cancer metastasis: twenty-eighth G.H.A. clowes memorial award lecture [J]. Cancer Research, 1990, 50:6130-6138
[6] 姚明，孔韩卫，戚锦芳，等．人黑色素瘤SCID小鼠高转移模型的筛选和建立[J]．上海实验动物科学，2001，21(4)：195-199
[7] Li Y, Tang Z, Ye S, et al. Establishment of human hepatocellular carcinoma cell line with spontaneous pulmonary metastasis through in vivo selection [J]. Chung-Hua i Hsueh Tsa Chih, 2002, 82(9): 601-605
[8] Yamaguchi K, Ura H, Yasoshima T, et al. Liver metastatic model for human gastric cancer established by orthotopic tumor cell implantation[J]. World Journal of Surgery, 2001, 25(2): 131-137
[9] Parsons SL, Watson SA, Brown PO. Matrix metalloproteinase[J]. Br J Surg, 1997, 84:160-166
[10] Iiabakk NB, Talbot L, Smith RA, et al. Matrix metalloproteinase 1(MMP1) and matrix metalloproteinase 9(MMP9), type IV colleagenase in colorectal cancer[J]. Cancer Res, 1996, 56:190-196
[11]Denhardt DT, Giachelli CM, Rittling SR. Role of Osteopontin in celluar signaling ang toxicant injurv[J]. Annu Rev Pharmacol Toxicol, 2001, 41: 723-749
[12] Tuck AB, Malley FP, Singhal H, et al. Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas[J]. Arch Pathol Lab Med, 1997, 121(6): 578-584
[13] Isaiah J. F idler. Critical factors in the biology of human cancer metastasis: Twenty-eighth G. H. A. Clowes Memorial Lecture [J]. Cancer Res, 1990, 50: 6130-6138
[14] Isaiah J. Fidler. Critical determinants of metastasis [J]. Cancer Biology, 2002, 12: 89-96
[15] Price JE. Influence of organ environment on metastasis [J]. Cancer Bull, 1987, 39(3): 162-167
[16] Repesh LA. A new in vitro assay for quantitating tumor cell invasion[J]. Invasion Metastasis. 1989, 9(3): 192-208
[17] Terranova VP, Hujanen ES,Loeb DM, et al. Use of a reconstituted basement membrane to measure cell invasiveness and select for highly invasive tumor cell[J]. Proc Natl Acad Sci USA. 1986, 83(2): 465-469
[18] Jacob K, Webber M, Benayahu D, et al. Osteonectin promotesprostate cancer cell migration and invasion: a possible mechanisnism for metastasis to bone[J]. Cancer Res, 1999, 59 (17): 4453-4457
[19] Muller A, Homey B, Soto H, et al. Involvement of chemokine receptors in breast cancer metastasis [J]. Nature, 2001, 410(6824): 50-56
[20] Gutman M, Singh RK, Xie K, et al. Regulation of IL-8expression in human melanoma cells by the organ environment[J]. Cancer Res, 1995, 55(11): 2470-2475
[21] 冀学宁，叶胜龙，李雁，等．肺组织粗提物促进人原发性肝癌细胞移动侵袭的研究[J]．中华实验外科杂志，2003，20(3)：219-220
[1] Tang ZY.Hepatocellular carcinoma[J]. J Gastroenterol Hepatol, 2000, 15(suppl): G1
[2] Sun FX, Tang ZY, Liu KD, et al. Establishment of a metastatic model of human hepatocellular carcinoma in nude mice via orthotopic implantation of histologically intact tissues[J]. Int Jcancer, 1996, 66:239-243
[3] Tian J, Tang ZY, Ye SL, et al. New human hepatocelluar carcinoma(HCC) cell line with highly metastatic potencial(MHCC97) and its expressions of the factors associated with metastasis [J]. Br J Cancer, 1999, 81: 814-821
[4] 郑建明，陶文照，郑唯强，等．人肝癌裸鼠皮下-肝原位种植瘤模型的建立[J]．第二军医大学学报，2000，21：456-459
[5] 郜永顺，陈孝平，李开艳，等．保持人肝癌生物学特性的人肝癌组织裸鼠肝内种植模型的建立[J]．中华普通外科杂志，2004，19(8)：468-470
[6] 刘虎，叶胜龙，薛琼，等．大鼠肝癌自发肺转移裸鼠模型的建立[J]．中华实验外科杂志，2004，21(1)：101-102
[7] 徐冰，姚明，闫明霞，等．人肝癌NOD-SCID小鼠原位移植模型的建立及其生物学特性的研究[J]．肿瘤，2006，26(11)：975-978
[8] 姚英民，刘青光，扬威，等．肝癌合并肝硬化时脾脏对机体免疫状态影响的实验研究[J]．中华肝胆外科杂志，2002，8(7)：428-430
[9] 顾伟，沈婕，翟笑枫．大鼠移植性肝癌模型生物学行为与分期的初步探讨[J]．中西医结合学报，2005，3(2)：136-138
[10] 蔡萍，张琳，丁仕义，等．兔VX2肝移植癌模型的建立及CT评价[J]．第三军医大学学报，2004，26(21)：1924-1927
[11] 杜文华，杨未晓，熊秀勤，等．兔转移性肝癌血管超声声学造影的实验研究[J]．重庆医学，2003，32(7)：873-875
[12] 唐浩，梁平．外周血GPC-3 mRNA在大鼠肝癌微转移中的意义[J]．消化外科，2005，4(1)：48-51
[13] 吴晓凤，林芷英，樊嘉，等．外周血甲胎蛋白mRNA定量与裸鼠肝癌术后复发转移的关系[J]．中华肝脏病杂志，2002，10(3)：189-192
[14] 李琦，孟庆莉，彭永海，等．大鼠移植性肝癌模型的制作．第二军医大学学报[J]，2002，23：1074
[15] 金昌德，施新猷，仇凯．转染pG基因HHCC细胞的裸鼠转移模型的复制[J]．中国兽医科技，2000，30(6)：15-17
[16] 师长宏，王晓武，王文勇，等．人肝癌原位移植转移模型特性实验研究[J]．中国实验动物学报，2001，9(1)：55-61
[17] 李雁，汤钊猷，叶胜龙，等．不同转移潜能人肝癌单克隆细胞株的分离和建立[J]．中华肝胆外科杂志，2001，7(11)：681-685
[18] 李雁，汤钊猷，叶胜龙，等．体内连续筛选法建立自发性肺转移人肝癌细胞系[J]．中华医学杂志，2002，82(9)：601-605
[19] 高进．癌细胞转移模型的建立及应用．见：高进，章静波主编．癌的侵袭及转移基础与临床．第1版，北京：科学出版社，2003，5
[20] Zeng JZ, Wang HY, Chen ZJ, et al. Molecular cloning and characterization of a novel gene which is highly expressed in hepatocellular carcinoma[J]. Oncogene, 2002, 21 (32): 4932-4943
[21] Wang XW, Hussain SP, Huo TI, et al. Molecular pathogenesis of human hepatocellular carcinoma[J]. Toxicology, 2002, 12 (181-182): 43-7
[22] Uchida T, Gao JP, Wang CX, et al. Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma[J]. Urology, 2002, 59(4): 615-20
[23] Capurro MI, Xiang YY, Lobe C, Filmus J. Glypican-3 promotes the growth of hepatocellular carcinoma by stimulating canonical Wnt signaling[J]. Cancer Res 2005, 65:6245-6254
[24] Sung YK, Hwang SY, Park MK, et al. GLYpican-3 is over expressed in human hepatocellular carcinoma[J]. Cancer Sci, 2003, 94(3): 259-262
[25] Midorikawa Y, Ishikawa S, Iwanari H, et al. Glypican-3, overexpressed in hepatocellular carcinoma, modulates FGF2 and BMP-7 signaling[J]. Int J Cancer, 2003, 103(4): 455-465
[26] 罗洪英，王海成，冯德云，等．肝细胞癌组织中PCNA和nm23的表达与转移的关系[J]．湖南医科大学学报，2003，28(1)：17
[27] Endo K, Ueda T, Ueyama J, et al.Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationship with tumor grade, clinicopathologic parameters, and patients survival[J]. Hum Patol, 2000, 31(5): 558-565
[28] 张宝华，陈汉．E-选择素及其配体Slex在肝癌转移中的意义[J]．中华外科杂志，2000，38(7)：534-536
[29] 朱继红，刘丽萍，童蓓燕，等．肝癌发生与转移过程中E-选择素在裸鼠肝、 肺、肾微血管内皮细胞的表达[J]．解剖学杂志，2001，24(3)：269-272
[30] Fawn Qi, Hanahan D, Weissman IL. L-selectin can facilitate metastasis to lymph nodes in a transgeninc mouse model of carnogenesis[J]. Proc Natl Acad Sci USA, 2001,98(7): 3976-3981
[31] 刘敏，王莉芬，朱杰，等．L-选择蛋白可能介导小鼠肝癌HCa-F细胞经淋巴道转移的研究[J]．解剖学报，2004，35(5)：502-508
[32] Torimura T, Ueno T, Kin M, et al. Lamininin deposition to type Ⅳ collagen enhances haptotaxis,chemokinesis, and adhesion of hepatoma cells through betal-integrins[J]. J Hepatol, 2001, 35(2): 245-253
[33] Carloni V, Mazzocca A, Pantaleo P, et al. The integrin, alpha6betall, is necessary for the matrix-dependent activation of FAK and MAP kinase and the migration of human hepatocacinoma cells [J]. Hepatology, 2001, 34(1): 42-49
[34] Xu Z, Shen MX, Ma DZ, et al. TGF-tetall promoted epithelial to mesenchymal transformation and cell adhesion contribute to TGF-betall enhenced cell migration in SMMC-7721 cells[J]. Cell Res, 2003, 3(5): 343-350
[35] 韦长元，李挺，刘剑仑，等．Ⅰ型细胞间黏附分子与肝癌侵袭转移的关系[J]．肝胆外科杂志，2001，9(1)：57-58
[36] 徐斌，居小萍，张晓华，等．细胞黏附分子在肝细胞癌发生及转移中的作用[J]．中华肝胆外科杂志，2002，8(7)：405-407
[37] 官成浓，杨丰，银正民，等．原发性肝癌患者血清可溶性细胞间黏附分子1的测定及其临床意义[J]．实用癌症杂志，2002，17(2)：164-166
[38] Endo K, Terade T. Protein expression of CD44(standard andvariant isoforms) in hepatocellular carcimoma: relationships with tumor grade, clinicopathologic parameters, p53 expression and patient survival[J]. J Hepatol, 2000, 32(1): 78-84
[39] NIETO-RODRIGUEZ A, HERNANADEZ-PANDO R, KERSHENOBICH D, et al. Expression of urokinase-type plas minogen activator in an experimental model of hepatocarcinoma[J]. Toxicology, 2001, 161 (1-2): 13-23
[40] Zheng Q, Tang ZY, Xue Q, et al. Invasion and metastasis of hepatocellular carcinoma in relation to urkinase-type plasminogen activator, its receptor and inhibitor[J]. J Cancer Res Clin Oncol, 2000, 126(11): 641-646
[41] 侯振江，张宗英．基质金属蛋白酶系统与恶性肿瘤[J]．国外医学临床生物化学与检验学分册，2004，25(1)：83-85
[42] Bodey B, Bodey B Jr, Siegel SE, et al. Immunocytochemical detction of MMP3 and 10 expression in hepatocellular carcinoma[J]. Anticancer Res, 2000, 20(6B): 4585-4590
[43] Sela BA. Matrix metalloproteinases: promoters of tumor progression and invasiveness. Isr Med Assoc [J]. 2002,4(4): 280-282
[44] 朱争艳，杜智，王毅军，等．钙粘素E和基质金属蛋白酶检测与肝癌预后关系研究[J]．临床肝胆病杂志，2002，18(4)：235-236
[45] 彭利，王顺祥，张风瑞，等．基质金属蛋白酶9和血管内皮生长因子与原发性肝癌侵袭转移关系研究[J]．中华肝胆外科杂志，2003，9(1)：42-44
[46] Park YN, Kin YB, Yang KM, et al. Increased expression of vascular endothelial growth factor and angiogenesis in the early stage of multistep hepatocarcinogensis[J]. Arch Pathol Lab Med, 2000, 124(7): 1061-1065
[47] Poon RT, Ng IO, Lau C, et al. Serum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma:a prospective study[J]. Ann Surg, 2001, 233(2): 227-235
[48] IGUCHI H, YOKOTA M, FUKUTOMI M, et al. A possible role of VEGF in osteolytic bone metastasis of hepatocellular carcinoma[J]. J Exp Clin Cancer Res, 2002, 21(3): 309-313
[49] 邓伟，梁力建．血管生成素和VEGF在人肝细胞癌血管生成作用机制的研究[J]．中国普通外科杂志，2005，14(6)：436-440
[50] Moon WS, Rhyu KH, Kang MJ, et al. Overexpression of VEGF and angiopoietin2: a key to high vascularity of hepatocellular carcinoma[J]. Mod Pathol, 2003, 16(6): 552-557
[51] Yoshiji H, Kuriyama S, Yoshii J, et al. Synergistic effect of basic fibroblast growth factor and vascular endothelial growth factor in murine hepatocellular carcinoma[J]. Hepatology, 2002, 35: 834-842